Recruiting
Hereditary haemorrhagic telangiectasia
RecruitingA Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia
Investigational
A Phase 3 Study of Engasertib to Evaluate Safety and Effectiveness in Adults with Moderate to Severe Hereditary Hemorrhagic Telangiectasia
Investigational
- Disease:Hereditary haemorrhagic telangiectasia
- Substances:Engasertib
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Engasertib



